CHARLESTON, S.C. (WCIV) — This weekend, over 2,000 "No Kings" protests are expected to take place across the nation, with some even occurring in Europe. Kristy Kinny, leader of the Indivisible ...

Smooth leather, shy pink suede, and Cactus Jack on the Back? Travis Scott’s 2026 Jordan 1 Low might be the cleanest OG of the year. Travis Scott x Air Jordan 1 Low ‘Shy Pink’ drops Summer 2026 for ...

Is Cactus Jack on his way back? I heard a rumor that the Travis Scott x Air Jordan 1 Low OG ‘Shy Pink’ sneakers (IQ7604-100) are finally dropping in 2026. The return of the reverse swoosh would add ...

Travis Scott's newest Air Jordan was initially expected to release in September, but the buzzy sneaker was pushed back later ...

The Air Jordan 12 ‘Pearl Pink’ drops November 21, 2025, in kids’ sizing for $150 — soft pink luxury meets classic MJ-era ...

When the New Orleans Pelicans added star guard Jordan Poole into the fold this offseason, one of the immediate takeaways was that there would now be a much-needed injection of NBA championship ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

First, it was a Michael Jordan and Kobe Bryant collectible that broke the record. Now we have His Airness paired with the Chosen One to add more lore to the history. There is no doubt that MJ and ...

BUFFALO, N.Y. (WIVB) — Three kids and one adult were hurt in a school bus crash in Wyoming County last week, the Wyoming County Sheriff’s Office said Wednesday. Police responded to the intersection of ...

Hospitals performed over 200,000 unnecessary back surgeries on older adults over a three-year period, and billed Medicare more than $1.9 billion for those low-value services, according to a Lown ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in China, Akeso and Summit Therapeutics’ ivonescimab has shown it can delay ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...